Laddar...
A glucose-responsive insulin therapy protects animals against hypoglycemia
Hypoglycemia is commonly associated with insulin therapy, limiting both its safety and efficacy. The concept of modifying insulin to render its glucose-responsive release from an injection depot (of an insulin complexed exogenously with a recombinant lectin) was proposed approximately 4 decades ago...
Sparad:
| I publikationen: | JCI Insight |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
American Society for Clinical Investigation
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5821182/ https://ncbi.nlm.nih.gov/pubmed/29321379 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.97476 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|